Results 21 to 30 of about 2,686 (226)

Hidradenitis suppurativa and social disadvantage: A nationwide administrative data study of the French hospitalized population

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 37, Issue 9, Page 1914-1919, September 2023., 2023
Abstract Background A lower socioeconomical status (SES) has been reported in patients suffering from hidradenitis suppurative (HS). However, limitations in the available studies prevent drawing definitive conclusions. Objectives The objective of this study was to assess the SES of HS patients using a specific SES indicator, the French DEPrivation ...
Julie Bulsei   +2 more
wiley   +1 more source

Non‐genetic biomarkers for ankylosing spondylitis: An umbrella review

open access: yesJournal of Clinical Laboratory Analysis, Volume 36, Issue 12, December 2022., 2022
Growing evidence has demonstrated that both genetic and environmental factors contribute substantially to the development of ankylosing spondylitis (AS), and molecular biomarkers might reflect the effect of both factors. In the past few decades, a number of systematic reviews and meta‐analyses evaluating the associations between various biomarkers and ...
Changming Lv   +7 more
wiley   +1 more source

Is Treatment in Patients With Suspected Nonradiographic Axial Spondyloarthritis Effective? Six‐Month Results of a Placebo‐Controlled Trial

open access: yesArthritis &Rheumatology, Volume 73, Issue 5, Page 806-815, May 2021., 2021
Objective To investigate the efficacy of 16‐week treatment with etanercept (ETN) in patients with suspected nonradiographic axial spondyloarthritis (SpA). Methods Tumor necrosis factor inhibitor–naive patients with inflammatory back pain with at least 2 SpA features and high disease activity (Bath Ankylosing Spondylitis Disease Activity Index score ≥4),
Tamara Rusman   +9 more
wiley   +1 more source

Sarcoidose et spondylarthrite ankylosante: une association rare [PDF]

open access: yes, 2011
L’association spondylarthrite ankylosante et sarcoïdose est rare, seize cas ont été publiés dans la littérature, nous en rapportons un nouveau cas. Cette association qui pose des problèmes diagnostiques est probablement fortuite du fait de l’absence de ...
Fatima Zahra El Ouazzani   +4 more
core   +2 more sources

SAPHO syndrome the therapeutical challenge [PDF]

open access: yesPraxis Medica, 2016
Introduction: Sapho syndrome is a syndrome characterizing with osteoarticular end dermatologic symptoms. Acronym 'SAPHO' means: S-Sinovitis, A-Acne, H-Hyperostosis, O-Osteytis. SAPHO syndrome has a 50 different names in existing literature.
Dejanović Bogdan   +5 more
doaj   +1 more source

The use of x-ray CT and MRI in the study of sacroiliac joints in patients with Behcet disease and acute anterior uveitis [PDF]

open access: yes, 2018
Objective: It's controversial if Behcet Disease (BD) must be included in the group of seronegative spondyloarthropathy (SpA). Our aim was to establish the prevalence of sacroiliitis (SI) in patients with BD using X-Ray, CT and MRI, in comparison with ...
CODACCI PISANELLI, Massimo   +8 more
core   +1 more source

Bamboo spine – X-ray findings of ankylosing spondylitis revisited

open access: yesSouth African Journal of Radiology, 2012
Ankylosing spondylitis is a debilitating disease that is one of the seronegative spondylarthropathies, affecting more males than females in the proportion of about 6:1 in the age group 15 - 35 years of age.
Antoinette Reinders, Matthys J van Wyk
doaj   +1 more source

A Longitudinal Study of Ambulatory Physician Encounters, Emergency Room Visits, and Hospitalizations by Patients with Rheumatoid Arthritis: A 13-year Population Health Study [PDF]

open access: yes, 2017
Objective. To determine total physician encounters, emergency room (ER) visits, and hospitalizations in an incident cohort of rheumatoid arthritis (RA) cases and matched control patients over 13 years. Methods.
Hanly, John G   +2 more
core   +1 more source

Characteristics of Patients with Psoriatic Arthritis Receiving Secukinumab and Reasons for Initiation: A US Retrospective Medical Chart Review

open access: yesRheumatology and Therapy, 2019
Introduction Secukinumab is a fully human anti-interleukin 17A monoclonal antibody approved for the treatment of psoriatic arthritis (PsA) in the United States.
Prashanth Sunkureddi   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy